Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN18149439Phase 2Completed
Phase 2, randomised, open-label trial of Tamalakyadi decoction and loratadine in allergic rhinitis (AR) (3 arms), sponsored by University of Colombo. Primary endpoints: Total Nasal Symptom Score and Serum immunoglobulin E level. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN18149439.